New MICS intraocular lens performs well in a multicenter study
AMSTERDAM — Micro-incision cataract surgery with implantation of the Incise IOL produced good, stable refractive outcomes with low deviation from target refraction, according to a study.
The Incise IOL (Bausch + Lomb) is made of hydrophilic acrylic material with a 22% water content. It is an aberration-free aspheric design with a 6mm optic and a power range from 0D to 30D in 0.5D increments. The 360° sharp posterior optic edge has been optimized for effective posterior capsule opacification (PCO) prevention.
“The dedicated Viscoject injector is intended for sub-2mm incision. You can inject the IOL though a 1.4mm incision, the smallest incision currently possible,” Burkhard Dick, MD, said at the European Society of Cataract and Refractive Surgeons meeting here.
Once in the eye, the IOL unfolds in a slow, controlled manner, he said.
Dick reported the 6-month results of a clinical study currently ongoing in 5 European sites. Biaxial (B-MICS) or micro coaxial (C-MICS) phacoemulsification procedures were equally performed using the Stellaris platform. the Viscoject inserter was used for either 1.8mm in the bag and 1.4mm wound-assist implantation.
“In the 70 eyes that have completed a 6-month follow-up, mean UCVA was 20/25 and mean BCVA was 20/20. Refractive outcomes were very good and stable, with a low deviation within 1D from target refraction,” Dick said.
No PCO was observed after 6 months, but long term results over the 2 years of the study will say more about the effectiveness of the sharp edge barrier effect of this lens.
Diclosure: Dick is a consultant to Bausch+Lomb.